Ruchira Papers (RUCHIRA)

Score breakdown: P/E: 3/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 1/1

Key Financials

Strengths

• Trades below book value at 0.80 P/B with book value at ₹150.65 per share
• Trailing P/E of 6.17 appears inexpensive, though earnings are declining
• Reasonable balance sheet with debt-to-equity of only 0.38
• Promoter holding is high at 68.67%, aligning management with shareholders
• Dividend yield of 4.56% provides some income support

Concerns

• Profit growth fell sharply by 87.62%, signaling significant earnings deterioration
• Sales declined 21.62%, reflecting weak demand or pricing pressure in the paper cycle
• Latest quarter net profit of ₹2 crore on ₹132 crore revenue implies extremely thin margins
• Piotroski F-Score of 3/9 suggests deteriorating financial health

AI Analysis

Ruchira Papers strikes me first as a cyclical business, not a franchise. Paper is a commodity; mills compete on cost, capacity utilization, and distribution. The 18.71% ROCE is respectable, and the 12.20% ROE is acceptable, but the latest numbers tell me the cycle has turned against the company. Sales fell 21.62%, profit collapsed 87.62%, and the latest quarter shows just ₹2 crore profit on ₹132 crore sales — a margin barely above breakeven. A Piotroski score of 3/9 reinforces that financial health has weakened recently. At ₹119.93, the stock trades at 0.80 times book value, below the ₹150.65 book value, and at 6.17 times trailing earnings. That looks cheap in the classic Graham sense, but I must be careful: the P/E is based on past earnings that are clearly deteriorating. With an 87.62% profit decline, the current earnings power is far lower than the multiple suggests. The 4.56% dividend yield is attractive, but I must question whether the dividend is sustainable if earnings stay this weak. The 68.67% promoter holding is a positive — owners are aligned with minority shareholders. Debt-to-equity of 0.38 is manageable, so the balance sheet is not the main worry. My main concern is earning power. A low P/B and a low P/E can trap investors when the business is at the top of the cycle, not the bottom. I need evidence of sales stabilization and margin recovery before treating this as a bargain. For now, I see an asset-backed cyclical stock with sound finances but no clear catalyst. I would put it on my watchlist, not on my buy list. Price is what you pay; value is what you get — and I need to know the future earning power before paying even a low price.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer